CSF levels of YKL-40, ICAM-1, VCAM-1, IL-15, and Flt-1 were increased in AD already from the preclinical and prodromal stages and were associated with CSF tau especially in Aβ-positive individuals [140]. This evidence concerns the gene MAPT and Alzheimer disease.